85. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 25. April 2019 (Posterbereich 28) 14:30-16:00

Postervorträge

Thrombembolieprävention bei Vorhofflimmern

Diskussionsleiter: H. Bogossian (Lüdenscheid), T. Tichelbäcker (Köln)

(P937) Risk paradox in the use novel of oral anticoagulants (NOAC) in patients with non-vavular atrial fibrillation in real world. Results of the prospective APAF-Registry.
    U. Zeymer, für die Studiengruppe: APAF-Register (Ludwigshafen am Rhein)
(P938) The role of implantable loop recorders and home monitoring to detect atrial fibrillation in patients with cryptogenic stroke: Results from a prospective single-center database
    Z. Arica, M. S. Thieme, B. Bellmann, S. C. R. Erlhöfer, K. Filipovic, L. Kuffer, T. G. Plenge, J. Terporten, J.-H. van den Bruck, J. Wörmann, A. Sultan, D. Steven, J. Lüker (Köln)
(P939) Depression predicts bleeding events, hospitalization and mortality in patients receiving oral anticoagulation: Insights from the thrombEVAL study
    M. Michal, L. Eggebrecht, S. Göbel, M. Panova-Noeva, M. Nagler, M. Lauterbach, C. Bickel, M. Beutel, J. Wiltink, T. Münzel, P. S. Wild, J. Prochaska (Mainz, Trier, Koblenz)
(P940) Impaired cerebrovascular reactivity and cognitive deficits in patients with atrial fibrillation
    A. Wutzler, H. Stecken, C. Krogias (Frankfurt (Oder), Bochum)
(P941)

Prescription of oral anticoagulation and reasons reported for non-use of OAC in patients with atrial fibrillation: Data from the German Atrial Fibrillation NETwork (AFNET) 2 Registry

    A. Gerth, M. Näbauer, P. Kirchhof, G. Steinbeck, G. Breithardt, für die Studiengruppe: AFNET (München, Starnberg, Münster; Birmingham, UK)
(P942) Impact of chronic kidney disease on intra-hospital and 1-year outcome after left atrial appendage closure – results from the prospective multicenter German LAARGE registry
    C. Fastner, C. Nienaber, J. Brachmann, J.-W. Park, U. Zeymer, R. Zahn, H. Sievert, T. Lewalter, V. Geist, M. Gödde, A. Krapivsky, M. Käunicke, J. M. Maier, B. Özdemir, M. Hochadel, S. Schneider, J. Senges, I. Akin, für die Studiengruppe: LAARGE (Mannheim, Coburg, Neubrandenburg, Ludwigshafen am Rhein, Frankfurt am Main, München, Bad Segeberg, Bremen, Mülheim an der Ruhr, Essen, Heilbronn; London, UK)
(P943) Time-dependent prediction of arrhythmia recurrences over 3 years follow-up using APPLE and MB-LATER scores in patients undergoing catheter ablation of atrial fibrillation.
    K. Schumacher, S. Zeynalova, P. Sommer, B. Dinov, A. Arya, A. Bollmann, D. Husser-Bollmann, G. Hindricks, J. Kornej (Leipzig, Bad Oeynhausen)
(P944) Site Variation in Antithrombotic Therapy for Atrial Fibrillation Patients after Percutaneous Coronary Intervention and Associated Outcomes: Findings from the Veterans Health Administration
    C. Olivier, J. Fan, M. Askari, K. Mahaffey, P. Heidenreich, A. Perino, G. Leef, M. Ho, R. Harrington, M. Turakhia (Freiburg im Breisgau; Palo Alto, Stanford, Denver, US)